Non-invasive treatment for diabetic neuropathy shows promise
Main Category: DiabetesArticle Date: 05 Jan 2004 - 0:00 PDT
'Non-invasive treatment for diabetic neuropathy shows promise'
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
5 (1 votes) |
A new, non-invasive device that uses near-infrared light to increase blood flow in diabetic peripheral neuropathy (DPN) has shown promising results in early clinical trials.
Treatment with the Anodyne Therapy System (ATS) appears to restores sensation, reduce pain, and improve balance in patients with diabetic peripheral neuropathy (DPN), according to a report published in the January issue of Diabetes Care.
ATS is thought to increase blood flow by dilating arteries and veins.
The auhors assessed the outcomes of 27 patients with DPN who were treated with placebo or active ATS for 2 weeks and then active therapy for 2 more weeks three times a week.
The study group included 9 patients who were insensitive to 5.07 and 6.65 test filaments and 18 who were only insensitive to the 5.07 filament.
In the group with milder sensory impairment, both 6 and 12 weeks of ATS were associated with a significant drop in the number of insensate sites. In contrast, no sensory improvements were seen with sham therapy.
ATS therapy was also tied to a reduction in neuropathic symptoms scores and with a fall in visual analog pain scores and the percentage of patients with substantial balance problems decreased from 90% to 17% with ATS.
But in the patients insensate to both test filaments, ATS did not produce significant improvements in sensation, neuropathic symptoms, or pain.
Although the results are 'encouraging,' the authors conclude 'more discreet quantitative sensory tests would be helpful in determining the exact degree of sensory improvement experienced after the administration of ATS treatments.'
Reference: Leonard D, Farooqi M and Myers S (2003) Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects With Diabetic Peripheral Neuropathy: A double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment Diabetes Care 27 (1) 168-172
Visit our diabetes section for the latest news on this subject.
MLA
26 May. 2012. <http://www.medicalnewstoday.com/releases/5186.php>
APA
http://www.medicalnewstoday.com/releases/5186.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Non-invasive treatment for diabetic neuropathy shows promise'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





